MAC pulmonary disease — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Macrolide-based multidrug therapy after susceptibility testing
Symptomatic nodular-bronchiectatic MAC disease with repeated positive cultures meets criteria for treatment consideration using multidrug therapy. Macrolide monotherapy risks resistance and should be avoided. NTM diagnosis requires clinical, radiological and microbiological correlation because single isolates may be contamination.
Reference: BTS NTM Guideline 2017; ERS/ATS/IDSA NTM guidance